Dan Ives Anthropics Growth Could Signal Broader AI Rally as Nasdaq 30000 Prediction Gains Renewed Attention NEXT Q1 2026 Earnings EPS Surprise of 2413 Beats Estimates Stock Declines Despite Progress Novartis Lifts FullYear Sales and Profit Outlook on Strong Drug Portfolio